Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dynamic Contrast-Enhanced MR Imaging for Soft Tissue Sarcomas.

Lorraine G. Shapeero1, Daniel Vanel, Koenraad L. Verstraete

  • 1Department of Radiology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, and Department of Radiology, Walter Reed Army Medical Center, Washington, District of Columbia.

Seminars in Musculoskeletal Radiology
|June 2, 2001
PubMed
Summary

Dynamic contrast-enhanced MRI detects viable soft tissue sarcomas by analyzing contrast agent uptake. This technique differentiates tumors from non-enhancing tissues and post-treatment changes, aiding diagnosis and monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fusion transcriptome profiling defines the monoclonal origin of multifocal epithelioid haemangioma of bone.

Histopathology·2023
Same author

High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series.

Cells·2020
Same author

Synovial chondrosarcoma: a single-institution experience with molecular investigations and review of the literature.

Histopathology·2020
Same author

Inflammation and infiltration: can the radiologist draw a line? MRI versus CT to accurately assess medullary involvement in parosteal osteosarcoma.

The International journal of biological markers·2020
Same author

Epithelioid hemangioma of bone: A unique case with multifocal metachronous bone lesions.

Journal of clinical orthopaedics and trauma·2019
Same author

Imaging of Upper Limb Tumors and Tumorlike Pathology.

Radiologic clinics of North America·2019

Area of Science:

  • Oncology
  • Radiology
  • Medical Imaging

Background:

  • Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is crucial for soft tissue sarcoma evaluation.
  • It aids in biopsy localization, assessing chemotherapeutic response, and long-term follow-up.
  • DCE-MRI's ability to detect viable tumor tissue is a key advantage.

Purpose of the Study:

  • To present the fundamental principles of contrast kinetics in soft tissue sarcomas.
  • To discuss current postprocessing methods for dynamic MRI studies.
  • To highlight DCE-MRI's role in differentiating tumor types and treatment effects.

Main Methods:

  • Analysis of contrast kinetics following bolus injection of contrast agent.
  • Application of postprocessing techniques: subtraction, first-pass imaging, time-intensity curves, and color-encoded methods.

Related Experiment Videos

  • Utilizing DCE-MRI's temporal resolution to observe early contrast uptake.

    • Main Results:

    • DCE-MRI delineates early contrast agent uptake in sarcomas within seconds of injection.
    • This rapid enhancement is nearly synchronous with arterial enhancement.
    • The technique effectively differentiates viable, enhancing tumors from necrotic or post-treatment changes.

    Conclusions:

    • DCE-MRI is a valuable tool for evaluating soft tissue sarcomas.
    • Its ability to assess contrast kinetics aids in distinguishing viable tumor from other tissues.
    • This imaging modality supports accurate diagnosis, treatment monitoring, and follow-up care.